ADMA BIOLOGICS, INC. Increase (Decrease) in Inventories
ADMA BIOLOGICS, INC. (ADMA) reported Increase (Decrease) in Inventories of $32.85 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-05
- ADMA BIOLOGICS, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was $17.21M, a 10.69% decline year-over-year.
- ADMA BIOLOGICS, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was $15.63M, a 700.46% increase year-over-year.
- ADMA BIOLOGICS, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was $9.80M.
- ADMA BIOLOGICS, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was $5.20M.
- ADMA BIOLOGICS, INC. increase (decrease) in inventories for fiscal 2025 was $36.23M.
- ADMA BIOLOGICS, INC. increase (decrease) in inventories for fiscal 2024 was -$2.67M, a 127.75% decline from fiscal 2023.
- ADMA BIOLOGICS, INC. increase (decrease) in inventories for fiscal 2023 was $9.63M, a 75.03% decline from fiscal 2022.
- ADMA BIOLOGICS, INC. increase (decrease) in inventories for fiscal 2022 was $38.56M, a 10.73% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $17.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $32.85M 10-Q · filed 2026-08-05 | $42.65M derived: sum of 3 quarters · filed 2026-08-05 | $47.85M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $15.63M 10-Q · filed 2026-05-06 | $25.43M derived: sum of 2 quarters · filed 2026-05-06 | $30.63M derived: sum of 3 quarters · filed 2026-05-06 | $49.91M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $9.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $15.00M derived: sum of 2 quarters · filed 2026-02-25 | $34.28M derived: sum of 3 quarters · filed 2026-08-05 | $36.23M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $5.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $24.48M derived: sum of 2 quarters · filed 2026-08-05 | $26.43M 10-Q · filed 2025-11-05 | $24.87M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $19.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $21.23M 10-Q · filed 2026-08-05 | $19.66M derived: sum of 3 quarters · filed 2026-08-05 | $11.65M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $1.95M 10-Q · filed 2026-05-06 | $387.00K derived: sum of 2 quarters · filed 2026-05-06 | -$7.62M derived: sum of 3 quarters · filed 2026-05-06 | -$5.54M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$9.57M derived: sum of 2 quarters · filed 2026-02-25 | -$7.50M derived: sum of 3 quarters · filed 2026-02-25 | -$2.67M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | -$8.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$5.93M derived: sum of 2 quarters · filed 2025-11-05 | -$1.10M 10-Q · filed 2025-11-05 | $8.69M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $6.90M 10-Q · filed 2025-08-06 | $16.69M derived: sum of 3 quarters · filed 2026-02-25 | $18.03M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $4.83M 10-Q · filed 2025-05-07 | $14.62M derived: sum of 2 quarters · filed 2026-02-25 | $15.95M derived: sum of 3 quarters · filed 2026-02-25 | $13.75M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $9.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $11.13M derived: sum of 2 quarters · filed 2026-02-25 | $8.92M derived: sum of 3 quarters · filed 2026-02-25 | $9.63M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | $1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$869.00K derived: sum of 2 quarters · filed 2024-11-07 | -$164.00K 10-Q · filed 2024-11-07 | -$163.94K 10-Q · filed 2023-11-08 | $202.46K derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-06-30 | -$2.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.50M 10-Q · filed 2024-08-08 | -$1.50M 10-Q · filed 2023-08-09 | -$1.13M derived: sum of 3 quarters · filed 2025-03-18 | $15.70M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-03-31 | $705.00K 10-Q · filed 2024-05-09 | $704.83K 10-Q · filed 2023-05-10 | $1.07M derived: sum of 2 quarters · filed 2025-03-18 | $17.91M derived: sum of 3 quarters · filed 2025-03-18 | $24.84M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2022-12-31 | $366.46K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $17.20M derived: sum of 2 quarters · filed 2025-03-18 | $24.13M derived: sum of 3 quarters · filed 2025-03-18 | $38.56M 10-K · filed 2025-03-18 | $38.56M 10-K · filed 2023-03-23 | |||
| 2022-09-30 | $16.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $23.77M derived: sum of 2 quarters · filed 2023-11-08 | $38.19M 10-Q · filed 2023-11-08 | $48.79M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $6.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $21.35M 10-Q · filed 2023-08-09 | $31.95M derived: sum of 3 quarters · filed 2024-02-28 | $46.38M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | $14.42M 10-Q · filed 2023-05-10 | $25.02M derived: sum of 2 quarters · filed 2024-02-28 | $39.45M derived: sum of 3 quarters · filed 2024-02-28 | $45.00M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | $10.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $25.02M derived: sum of 2 quarters · filed 2024-02-28 | $30.58M derived: sum of 3 quarters · filed 2024-02-28 | $43.19M 10-K · filed 2024-02-28 | $43.19M 10-K · filed 2022-03-24 | |||
| 2021-09-30 | $14.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $19.98M derived: sum of 2 quarters · filed 2022-11-09 | $32.59M 10-Q · filed 2022-11-09 | $44.37M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $5.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $18.16M 10-Q · filed 2022-08-10 | $29.95M derived: sum of 3 quarters · filed 2022-08-10 | $43.70M derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | $12.61M 10-Q · filed 2022-05-11 | -$12.61M 10-Q · filed 2021-05-12 | $24.39M derived: sum of 2 quarters · filed 2022-05-11 | $38.14M derived: sum of 3 quarters · filed 2022-05-11 | $40.31M derived: sum of 4 quarters · filed 2022-05-11 | |||
| 2020-12-31 | $11.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $25.53M derived: sum of 2 quarters · filed 2022-03-24 | $27.69M derived: sum of 3 quarters · filed 2022-03-24 | $28.47M 10-K · filed 2022-03-24 | -$28.47M 10-K · filed 2021-03-25 | |||
| 2020-09-30 | $13.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $15.91M derived: sum of 2 quarters · filed 2021-11-10 | $16.69M 10-Q · filed 2021-11-10 | -$16.69M 10-Q · filed 2020-11-05 | $3.91M derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $2.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $2.94M 10-Q · filed 2021-08-11 | -$2.94M 10-Q · filed 2020-08-05 | -$9.84M derived: sum of 3 quarters · filed 2021-08-11 | -$26.54M derived: sum of 4 quarters · filed 2021-08-11 | |||
| 2020-03-31 | $775.93K 10-Q · filed 2021-05-12 | -$775.93K 10-Q · filed 2020-05-06 | -$12.00M derived: sum of 2 quarters · filed 2021-05-12 | -$28.70M derived: sum of 3 quarters · filed 2021-05-12 | -$33.90M derived: sum of 4 quarters · filed 2021-05-12 | |||
| 2019-12-31 | -$12.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$29.47M derived: sum of 2 quarters · filed 2021-03-25 | -$34.68M derived: sum of 3 quarters · filed 2021-03-25 | -$34.65M 10-K · filed 2021-03-25 | $34.65M 10-K · filed 2020-03-13 | |||
| 2019-09-30 | -$16.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$21.90M derived: sum of 2 quarters · filed 2020-11-05 | -$21.87M 10-Q · filed 2020-11-05 | $21.87M 10-Q · filed 2019-11-06 | -$17.13M derived: sum of 4 quarters · filed 2020-11-05 | |||
| 2019-06-30 | -$5.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$5.18M 10-Q · filed 2020-08-05 | $5.18M 10-Q · filed 2019-08-08 | -$436.41K derived: sum of 3 quarters · filed 2020-08-05 | $1.19M derived: sum of 4 quarters · filed 2020-08-05 | |||
| 2019-03-31 | $25.31K 10-Q · filed 2020-05-06 | $4.76M derived: sum of 2 quarters · filed 2020-05-06 | $6.39M derived: sum of 3 quarters · filed 2020-05-06 | $6.20M derived: sum of 4 quarters · filed 2020-05-06 | ||||
| 2018-12-31 | $4.74M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $6.37M derived: sum of 2 quarters · filed 2020-03-13 | $6.18M derived: sum of 3 quarters · filed 2020-03-13 | $5.99M 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | $1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $1.44M derived: sum of 2 quarters · filed 2019-11-06 | $1.25M 10-Q · filed 2019-11-06 | $458.46K derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2018-06-30 | -$191.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$381.21K 10-Q · filed 2019-08-08 | -$1.17M derived: sum of 3 quarters · filed 2019-08-08 | -$903.76K derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$189.38K 10-Q · filed 2019-05-08 | -$980.17K derived: sum of 2 quarters · filed 2019-05-08 | -$711.93K derived: sum of 3 quarters · filed 2019-05-08 | -$1.07M derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | -$790.79K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$522.55K derived: sum of 2 quarters · filed 2019-03-13 | -$877.66K derived: sum of 3 quarters · filed 2019-03-13 | -$589.32K 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | $268.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$86.87K derived: sum of 2 quarters · filed 2018-11-09 | $201.47K 10-Q · filed 2018-11-09 | $603.88K derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | -$355.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$66.77K 10-Q · filed 2018-08-10 | $335.65K derived: sum of 3 quarters · filed 2018-08-10 | $744.05K derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-03-31 | $288.35K 10-Q · filed 2018-05-14 | $690.76K derived: sum of 2 quarters · filed 2018-05-14 | $1.10M derived: sum of 3 quarters · filed 2018-05-14 | $1.26M derived: sum of 4 quarters · filed 2018-05-14 | ||||
| 2016-12-31 | $402.41K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $810.82K derived: sum of 2 quarters · filed 2018-03-29 | $970.91K derived: sum of 3 quarters · filed 2018-03-29 | $1.57M 10-K · filed 2018-03-29 | ||||
| 2016-09-30 | $408.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $568.50K derived: sum of 2 quarters · filed 2017-11-03 | $1.17M 10-Q · filed 2017-11-03 | $1.79M derived: sum of 4 quarters · filed 2017-11-03 | ||||
| 2016-06-30 | $160.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $763.55K 10-Q · filed 2017-08-11 | $1.38M derived: sum of 3 quarters · filed 2017-08-11 | $1.76M derived: sum of 4 quarters · filed 2017-08-11 | ||||
| 2016-03-31 | $603.47K 10-Q · filed 2017-05-12 | $1.22M derived: sum of 2 quarters · filed 2017-05-12 | $1.60M derived: sum of 3 quarters · filed 2017-05-12 | $2.11M derived: sum of 4 quarters · filed 2017-05-12 | ||||
| 2015-12-31 | $614.96K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $992.88K derived: sum of 2 quarters · filed 2017-02-24 | $1.50M derived: sum of 3 quarters · filed 2017-02-24 | $1.74M 10-K · filed 2017-02-24 | ||||
| 2015-09-30 | $377.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $889.88K derived: sum of 2 quarters · filed 2016-11-10 | $1.12M 10-Q · filed 2016-11-10 | $1.38M derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | $511.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $744.13K 10-Q · filed 2016-08-12 | $1.00M derived: sum of 3 quarters · filed 2016-08-12 | $1.34M derived: sum of 4 quarters · filed 2016-08-12 | ||||
| 2015-03-31 | $232.17K 10-Q · filed 2016-05-13 | $488.38K derived: sum of 2 quarters · filed 2016-05-13 | $828.33K derived: sum of 3 quarters · filed 2016-05-13 | $956.44K derived: sum of 4 quarters · filed 2016-05-13 | ||||
| 2014-12-31 | $256.21K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $596.16K derived: sum of 2 quarters · filed 2016-03-23 | $724.27K derived: sum of 3 quarters · filed 2016-03-23 | $39.70K 10-K · filed 2016-03-23 | ||||
| 2014-09-30 | $339.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $468.06K derived: sum of 2 quarters · filed 2015-11-10 | -$216.50K 10-Q · filed 2015-11-10 | $247.48K derived: sum of 4 quarters · filed 2015-11-10 | ||||
| 2014-06-30 | $128.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$556.46K 10-Q · filed 2015-08-11 | -$92.47K derived: sum of 3 quarters · filed 2015-08-11 | $197.44K derived: sum of 4 quarters · filed 2015-08-11 | ||||
| 2014-03-31 | -$684.57K 10-Q · filed 2015-05-12 | -$220.58K derived: sum of 2 quarters · filed 2015-05-12 | $69.34K derived: sum of 3 quarters · filed 2015-05-12 | -$22.77K derived: sum of 4 quarters · filed 2015-05-12 | ||||
| 2013-12-31 | $463.99K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $753.90K derived: sum of 2 quarters · filed 2015-03-09 | $661.79K derived: sum of 3 quarters · filed 2015-03-09 | $403.46K 10-K · filed 2015-03-09 | ||||
| 2013-09-30 | $289.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $197.81K derived: sum of 2 quarters · filed 2014-11-10 | -$60.52K 10-Q · filed 2014-11-10 | $195.39K derived: sum of 4 quarters · filed 2014-11-10 | ||||
| 2013-06-30 | -$92.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | -$350.44K 10-Q · filed 2014-08-11 | -$94.53K derived: sum of 3 quarters · filed 2014-08-11 | -$287.88K derived: sum of 4 quarters · filed 2014-08-11 | ||||
| 2013-03-31 | -$258.33K 10-Q · filed 2014-05-12 | -$2.42K derived: sum of 2 quarters · filed 2014-05-12 | -$195.77K derived: sum of 3 quarters · filed 2014-05-12 | -$168.02K derived: sum of 4 quarters · filed 2014-05-12 | ||||
| 2012-12-31 | $255.91K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $62.55K derived: sum of 2 quarters · filed 2014-03-28 | $90.31K derived: sum of 3 quarters · filed 2014-03-28 | $118.25K 10-K · filed 2014-03-28 | ||||
| 2012-09-30 | -$193.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$165.60K derived: sum of 2 quarters · filed 2013-11-12 | -$137.66K 10-Q · filed 2013-11-12 | $35.25K derived: sum of 4 quarters · filed 2013-11-12 | ||||
| 2012-06-30 | $27.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $55.70K 10-Q · filed 2013-08-12 | $228.60K derived: sum of 3 quarters · filed 2013-08-12 | $228.60K derived: sum of 4 quarters · filed 2013-08-12 | ||||
| 2012-03-31 | $27.94K 10-Q · filed 2013-05-14 | $200.85K derived: sum of 2 quarters · filed 2013-05-14 | $200.85K derived: sum of 3 quarters · filed 2013-05-14 | -$149.04K derived: sum of 4 quarters · filed 2013-05-14 | ||||
| 2011-12-31 | $172.91K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-06 | $172.91K derived: sum of 2 quarters · filed 2013-03-06 | -$176.98K derived: sum of 3 quarters · filed 2013-03-06 | -$308.48K 10-K · filed 2013-03-06 | ||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | -$349.89K derived: sum of 2 quarters · filed 2012-11-13 | -$481.39K 10-Q · filed 2012-11-13 | |||||
| 2011-06-30 | -$349.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$481.39K 10-Q · filed 2012-08-14 | ||||||
| 2011-03-31 | -$131.50K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |